Coya Therapeutics to Participate at Upcoming September Investor Conferences

Core Viewpoint - Coya Therapeutics, Inc. is actively engaging with investors through participation in two upcoming conferences, highlighting its focus on developing biologics for neurodegenerative disorders [1][2]. Company Overview - Coya Therapeutics, Inc. is a clinical-stage biotechnology company based in Houston, TX, specializing in treatments that enhance regulatory T cell (Treg) function to address systemic inflammation and neuroinflammation [4]. - The company’s investigational product pipeline includes Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy, aimed at restoring the anti-inflammatory and immunomodulatory functions of Tregs [5]. Upcoming Events - Coya will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025, at 10 am ET, with a presentation by CEO Arun Swaminathan [2]. - The company will also participate in the Lake Street Capital Markets 9th Annual Best Ideas Growth Conference on September 11, 2025, where management will be available for one-on-one meetings [2]. Webcast Information - Live and archived webcasts of the presentations will be accessible on the company's website under the Investor Relations section, with replays available for 90 days [3].